Concepedia
Statistics
Publications
2
Citations
66
H-Index
Active since
2012
Affiliations
University of Washington(Current)
Comprehensive Cancer Centers of Nevada
Tokai Pharmaceuticals (United States)
Neurology Centers of the Carolinas
Dana-Farber Cancer Institute
Jodie P. Morrison is an author at University of Washington specializing in medicine, oncology, and cancer pharmacology.
Publications per year
2012–2012
Phase I clinical trial of galeterone (TOK-001), a multifunctional antiandrogen and CYP17 inhibitor in castration resistant prostate cancer (CRPC).
Bruce Montgomery, Mario A. Eisenberger, Matthew B. Rettig et al. · Journal of Clinical Oncology · 2012 · 35 citations
Medicine, Oncology, Pharmacology +17
Abstract CT-07: ARMOR1: Safety of galeterone (TOK-001) in a Phase 1 clinical trial in chemotherapy naive patients with castration resistant prostate cancer (CRPC)
Mary‐Ellen Taplin, Franklin Chu, Jodie P. Morrison et al. · Cancer Research · 2012 · 31 citations
Medicine, Oncology, Pharmacology +15
1–2 of 2